Melanoma: open trials in Taiwan

• NCT06953089

  DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

  Trial Treatment · Phase 2 · DualityBio Inc.

  TWN02-0, Taipei · TWN01-0, Taipei

  Registry updated 2026-10-29

• NCT06172478

  A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  Trial Treatment · Phase 2 · Daiichi Sankyo

  Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei · Koo Foundation Sun Yat-Sen Cancer Center, Taipei · MacKay Memorial Hospital, Taipei · Chang Gung Memorial Hospital, Taoyuan

  Registry updated 2026-10-26

• NCT06330064

  A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  Trial Treatment · Phase 1/2 · Daiichi Sankyo

  China Medical University Hospital, Taichung · National Cheng Kung University Hospitalx, Tainan · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei · Tri-Service General Hospital, Taipei · Koo Foundation Sun Yat-Sen Cancer Center, Taipei

  Registry updated 2026-10-26

• NCT05914116

  A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  Trial Treatment · Phase 1/2 · DualityBio Inc.

  Kaohsiung City · Kaohsiung City · New Taipei City · Taipei · Taipei · Taipei · Taipei · Taipei · Taoyuan

  Registry updated 2026-10-21

• NCT04913285

  A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

  Trial Treatment · Phase 1 · Pierre Fabre Medicament

  National Taiwan University Hospital, Taipei

  Registry updated 2026-09-02

• NCT04198766

  Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  Trial Treatment · Phase 1/2 · Inhibrx Biosciences, Inc

  Changhua Christian Hospital (CCH), Changhua · E-Da Cancer Hospital, Kaohsiung City · Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH), Kaohsiung City · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei

  Registry updated 2026-07-29

• NCT06952400

  The Registry Study of Genetic Alterations of Melanoma in Taiwan

  Research · National Health Research Institutes, Taiwan

  Chang-Gung Memorial Hospital - Chiayi, Chiayi City · Kaohsiung Medical University, Kaohsiung City · Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City · National Taiwan University Hospital ,NTUH Hsin-Chu Branch, Sindian City · China Medical University Hospital, Taichung · Chung Shan Medical University Hospital, Taichung · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei · Taipei Medical University -Ministry of Health and Welfare Shuang-Ho Hospital, Taipei · Koo Foundation Sun Yat-Sen Cancer Center, Taipei · Wan Fang Hospital, Taipei Medical University, Taipei · National Taiwan University Hospital, Taipei · MacKay Memorial Hospital, Taipei · Chang Gung Memorial Hospital, Linkou, Taoyuan · Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan

  Registry updated 2025-05-06

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error